Nasdaq Small-Cap Boom: Biotech & Micro-Caps Soar Over 100%
By ATTN Desk · Editorial oversight: Sean Han
Market Recap: August 21, 2025
The small‐cap segment of the Nasdaq saw a broad rally on August 21, 2025, with several names doubling or better on heavy volume. Biotech and micro-cap issuers led gains, propelled by clinical updates, strategic announcements and short-squeeze dynamics. Volume was especially elevated in names such as APM, PTIX and AEMD as investors chased momentum.
Key Movers at a Glance
| Ticker | ATTN Price | Current Price | Volume | Price Change % |
|---|---|---|---|---|
| PTIX | 4.16 | 4.16 | 83,496,118 | +74.65% |
| AEMD | 1.93 | 1.93 | 69,403,340 | +75.64% |
| ASBP | 0.52 | 0.52 | 26,257,254 | +31.69% |
| GWAV | 0.10 | 0.10 | 14,151,004 | +43.19% |
| APM | 3.33 | 3.33 | 198,649,426 | +104.17% |
| THAR | 4.86 | 4.86 | 60,670,165 | +47.46% |
| SLQT | 2.56 | 2.56 | 12,312,805 | +26.15% |
| STFS | 0.19 | 0.19 | 9,015,084 | +41.82% |
| MODV | 0.65 | 0.65 | 9,562,375 | +63.61% |
| CATO | 3.88 | 3.88 | 1,214,011 | +28.17% |
| COTY | 3.82 | 3.82 | 24,664,363 | +5.60% |
| SUGP | 0.42 | 0.42 | 327,120 | +21.95% |
| RMSG | 4.05 | 4.05 | 922,888 | +157.55% |
| ZYBT | 6.53 | 6.53 | 443,987 | +95.54% |
| LASE | 4.04 | 4.04 | 2,311,713 | +36.45% |
| IMRX | 4.53 | 4.53 | 4,071,389 | +27.03% |
| FLYE | 0.69 | 0.69 | 7,667,666 | +46.49% |
| RENT | 5.80 | 5.80 | 1,288,642 | +29.14% |
| ANTE | 2.23 | 2.23 | 620,234 | +87.22% |
Market Trends and Patterns
Trading on Tuesday was characterized by sharp gains across penny and small‐cap issues, with no name posting a loss among the 19 stocks tracked. The average price gain exceeded 59%, underscoring an aggressive chase for high-beta names. Volume readings were extreme in the top performers—APM topped 198 million shares traded, followed by PTIX at 83 million and AEMD at 69 million—reflecting both institutional and retail interest.
Biotech tickers dominated the leaderboard. AEMD jumped 75.6% after an independent data safety monitoring board approved its hemopurifier trial, while ZYBT climbed 95.5% on renewed acquisition rumors. Real‐estate tech pick RMSG surged 157.5% as a stake disclosure fueled a short squeeze. The breadth of sector participation suggests that, at least for the day, momentum outweighed fundamental scrutiny.
Small-cap rally by Lina Bob
Highlights of Significant Moves
- APM (Aptorum Group) rallied 104.2% on record volume following news of a proposed merger, marking its highest one‐day percentage gain in over a year.
- RMSG (Real Messenger Corp) surged 157.5% as a new 5.5% stake filing triggered short covering.
- PTIX (Protagenic Inc.) and AEMD both saw triple-digit relative volume, gaining 74.6% and 75.6%, respectively, amid clinical trial and partnership updates.
- ZYBT (Zhengye Biotechnology) jumped nearly 96% after addressing a late‐filing issue, with investors focusing on its R&D pipeline expansion.
- ANTE (AirNet Technology) climbed 87.2% when it regained Nasdaq compliance, boosting advertising network prospects.
Volume surges were notable beyond the leaders. GWAV and STFS each more than doubled their 30-day average turnover, validating interest in the most speculative names. Meanwhile, COTY, a larger‐cap outlier, posted a modest 5.6% rise on 24.7 million shares as investors pared back positions after a recent run.
Tl;dr
- Broad small-cap rally: All 19 tracked names closed higher; average gain +59.0%.
- Top volume: APM 198 M, PTIX 83 M, AEMD 69 M.
- Biggest movers: RMSG +157.5%, APM +104.2%, ZYBT +95.5%, ANTE +87.2%.
- Sector theme: Biotech and micro-caps led gains on trial news, filings, and M&A activity.
- Market signal: Momentum‐driven trading with heavy volume; fundamental drivers secondary for the session.